Patent assignee · CH · COMPANY

Carderm Capital L.P.

3Patents
0Active
3Granted
27Portfolio score

Filing activity: May 6, 1993 → Feb 27, 1995

Most-cited patents

PatentTitleAreaCited byStatus
US5286497A Diltiazem formulation Human Necessities 108 Expired
US5439689A Diltiazem formulation Human Necessities 98 Expired
US5470584A Diltiazem formulation Human Necessities 54 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.